Rayonier (RYN)
(Delayed Data from NYSE)
$30.35 USD
+0.10 (0.33%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $30.36 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.35 USD
+0.10 (0.33%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $30.36 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth C Momentum D VGM
Zacks News
Down -7.36% in 4 Weeks, Here's Why You Should You Buy the Dip in Rayonier (RYN)
by Zacks Equity Research
Rayonier (RYN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Here's Why Rayonier (RYN) is an Apt Portfolio Pick for Now
by Zacks Equity Research
A solid timberland portfolio and developments in biogenetics and cloning are likely to aid Rayonier (RYN).
Rayonier (RYN) Q4 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Rayonier's (RYN) Q4 earnings meet estimates despite lower-than-anticipated revenues. The pro forma operating income declines in most segments excluding Real Estate. It has issued its 2024 outlook.
Rayonier (RYN) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Rayonier (RYN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Countdown to Rayonier (RYN) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Rayonier (RYN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Rayonier (RYN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Rayonier (RYN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rayonier (RYN) Completes the Oregon Timberland Divestiture
by Zacks Equity Research
Rayonier (RYN) strategically divests Oregon timberland, aligning with its capital plans for enhanced shareholder value and long-term financial resilience.
Rayonier (RYN) Sells Timberland, Announces Special Dividend
by Zacks Equity Research
Rayonier (RYN) sells 55,000 acres of timberland in Oregon for $242 million as part of its capital structure realignment plan. The proceeds were used to repay debt and distribute a special dividend.
Rayonier (RYN) Up 7.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Rayonier (RYN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is it Wise for Investors to Retain Rayonier (RYN) Stock Now?
by Zacks Equity Research
While a solid timberland portfolio, developments in biogenetics and cloning, and capital realignment moves are likely to aid Rayonier (RYN), weak export market demand and high interest rates are woes.
Surging Earnings Estimates Signal Upside for Rayonier (RYN) Stock
by Zacks Equity Research
Rayonier (RYN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Rayonier (RYN) Q3 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Rayonier's (RYN) New Zealand Timber and Real Estate segments' pro-forma operating income improve year over year, while its Southern Timber and Pacific Northwest Timber segments show weakness.
Rayonier (RYN) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Rayonier (RYN) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Rayonier (RYN) Hurt by Soft Demand, Low Construction Activity
by Zacks Equity Research
Softer end-market demand and a decline in construction activity in some markets due to high interest rates are likely to affect Rayonier's (RYN) profitability.
Rayonier (RYN) Q2 Earnings & Revenues Miss Estimates, Fall Y/Y
by Zacks Equity Research
Rayonier's (RYN) Q2 results miss estimates on lower-than-anticipated revenues. The pro forma operating income declines in almost all segments except trading. It has also issued a revised 2023 outlook.
Compared to Estimates, Rayonier (RYN) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Rayonier (RYN) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Rayonier (RYN) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Rayonier (RYN) delivered earnings and revenue surprises of -44.44% and 0.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Potlatch (PCH) Q2 Earnings Miss Estimates
by Zacks Equity Research
Potlatch (PCH) delivered earnings and revenue surprises of -33.33% and 6.71%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Is Rayonier (RYN) Down 0.6% Since Last Earnings Report?
by Zacks Equity Research
Rayonier (RYN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rayonier (RYN) Earnings & Revenues Miss Estimates in Q1
by Zacks Equity Research
Rayonier's (RYN) Q1 results are weaker than expected on lower-than-anticipated revenues. The pro-forma operating income declines across all segments.
Rayonier (RYN) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Rayonier (RYN) delivered earnings and revenue surprises of -87.50% and 9.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Trex (TREX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Trex (TREX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Rayonier (RYN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Rayonier (RYN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Potlatch (PCH) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Potlatch (PCH) delivered earnings and revenue surprises of 91.67% and 10.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Rayonier (RYN) Down 9.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Rayonier (RYN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.